3kf7 | pdb_00003kf7
From Proteopedia
Crystal Structure of Human p38alpha Complexed With a Triazolopyrimidine compound
| ||||||||||||
Structural highlights
Evolutionary Conservation![]() Check, as determined by ConSurfDB. You may read the explanation of the method and the full data available from ConSurf. Publication Abstract from PubMedThe structure based drug design, synthesis and structure-activity relationship of a series of C6 sulfur linked triazolopyridine based p38 inhibitors are described. The metabolic deficiencies of this series were overcome through changes in the C6 linker from sulfur to methylene, which was predicted by molecular modeling to be bioisosteric. X-ray of the ethylene linked compound 61 confirmed the predicted binding orientation of the scaffold in the p38 enzyme. Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition.,Jerome KD, Rucker PV, Xing L, Shieh HS, Baldus JE, Selness SR, Letavic MA, Braganza JF, McClure KF Bioorg Med Chem Lett. 2010 Jan 15;20(2):469-73. Epub 2009 Nov 26. PMID:19969459[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
Contents | ||||||||||||||||||||||
This page was last modified 13:16, 29 September 2014.